Angiodynamics (ANGO) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Angiodynamics (ANGO) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.45 Bn | 142.05 Bn | 1.83 Bn | 17.38% |
| 2 | Becton Dickinson | 42.00 Bn | 40.99 Bn | 2.15 Bn | -282.67% |
| 3 | Medline | 29.98 Bn | 35.82 Bn | 1.84 Bn | -25.78% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 9.23% |
| 5 | West Pharmaceutical Services | 23.82 Bn | 23.30 Bn | 296.40 Mn | 56.71% |
| 6 | Solventum | 14.10 Bn | 14.10 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.20 Bn | 13.06 Bn | 735.40 Mn | -188.83% |
| 8 | Align Technology | 12.18 Bn | 11.12 Bn | 736.59 Mn | 20.94% |
| 9 | Baxter International | 10.46 Bn | 8.41 Bn | 891.00 Mn | -96.77% |
| 10 | Angiodynamics | 511.63 Mn | 473.82 Mn | 41.48 Mn | -83.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -83.44% |
| Nov 30, 2025 | 40.86% |
| Aug 31, 2025 | 14.81% |
| May 31, 2025 | 55.02% |
| Feb 28, 2025 | 97.65% |
| Nov 30, 2024 | 63.03% |
| Aug 31, 2024 | -127.89% |
| May 31, 2024 | 37.35% |
| Feb 29, 2024 | -1,879.29% |
| Nov 30, 2023 | -242.30% |
| Aug 31, 2023 | 452.85% |
| May 31, 2023 | -242.59% |
| Feb 28, 2023 | -91.31% |
| Nov 30, 2022 | -1.62% |
| Aug 31, 2022 | -86.52% |
| May 31, 2022 | 67.81% |
| Feb 28, 2022 | -39.90% |
| Nov 30, 2021 | -95.67% |
| Aug 31, 2021 | -63.36% |
| May 31, 2019 | 536.93% |